Patent ID: 7879876

Claim:
A compound of Formula (Ia), wherein: R 2 and R 3 are independently selected from: hydrogen, halogen, linear or branched C 1 -C 6 alkyl, optionally substituted with one or more substituents selected from the group consisting of halogen, hydroxy, linear or branched C 1 -C 6 alkoxy, phenoxy, linear or branched C 1 -C 6 alkoxy, phenyl, optionally substituted with one or more substituents selected from the group consisting of halogen, hydroxy, linear or branched C 1 -C 6 alkyl, phenyl-linear or branched C 1 -C 6 alkyl, said phenyl optionally substituted with one or more substituents selected from the group consisting of halogen, hydroxy, linear or branched C 1 -C 6 alkyl, a three to six member heterocyclic group having at least a heteroatom selected from the group consisting of oxygen, nitrogen and sulfur; R 13 is selected from H, linear or branched C 1 -C 6 alkyl; R 14 is selected from linear or branched C 1 -C 8 alkyl, optionally substituted with one or more halogen atoms and/or hydroxy groups, said C 1 -C 8 alkyl optionally containing one or more unsaturated C—C bonds or containing one or more oxygen or sulfur atoms in the alkyl chain, C 3 -C 8 cycloalkyl, optionally substituted with a carboxy or a linear or branched C 1 -C 4 alkoxycarbonyl group, phenyl, phenyl-linear or branched C 1 -C 6 alkyl, said C 1 -C 6 alkyl optionally containing one oxygen atom, a heterocyclic or heterocycloalkyl group selected from the group consisting of: 1,3-dioxolane, 2,2-dimethyl-1,3-dioxolane, thiophene, 1-methyl-1-morpholino-4-ylethyl, pyrimidine, pyridine, said pyridine optionally substituted with a hydroxy or C 1 -C 6 alkoxy group; pyridinyl-linear or branched C 1 -C 4 alkyl; piperidine, said piperidine optionally substituted with phenyl-C 1 -C 4 alkyl; furan, tetrahydrofuran; 2-tetrahydrofuran-2-ylethyl, pyrrolidine N-carboxylic acid, C 1 -C 4 linear or branched N-alkoxycarbonylpyrrolidin-2-yl; tetrahydropyran; or R 13 and R 14 taken together form a C 3 -C 8 cycloalkyl; n is an integer selected from 0 and 1; as well as its geometrical isomers, its optically active forms as enantiomers, diastereomers, tautomers, racemate forms, as well as pharmaceutically acceptable salts thereof.